Author

admin

Browsing

The Mariners made a huge splash on the eve of the MLB trade deadline, agreeing to a deal that will bring slugger Eugenio Suárez back to Seattle from the Arizona Diamondbacks, according to a person with knowledge of the deal.

The person spoke to USA TODAY Sports on the condition of anonymity because the deal wasn’t official and pending medical reviews.

It’s the second big trade between the clubs in the past week with the Mariners also acquiring first baseman Josh Naylor from the Diamondbacks in a deal on July 24.

Suárez has 36 home runs and 87 RBIs and is on pace to become the first player traded in-season to finish with 50 homers since Mark McGwire in 1996. He has been on fire for the past 12 months, clubbing 53 home runs with 134 RBIs in 161 games beginning on July 28, 2024 – including a four-homer game in April, tying the MLB record.

Mariners third basemen have totaled just five home runs and 35 RBIs this season, bottom-five in the majors in both categories.

Suárez became one of baseball’s top power hitters at the end of the 2010s with the Cincinnati Reds, slugging 34 home runs in 2018 and 49 in 2019, topping 100 RBIs each year. But his struggles began after his 49-homer campaign, posting a .221 average – including a .198 mark in 2021 – from 2020-2023, the latter two years with the Mariners.

The Mariners traded Suárez to the Diamondbacks after the 2023 season and he totaled 53 home runs with a .751 OPS in 312 games during his first tenure in Seattle.

Suárez is a free agent at the end of the season and his exploits over the past year may have earned him a multi-year deal.

Eugenio Suárez trade details

Seattle Mariners receive:

  • 3B Eugenio Suárez

Arizona DIamondbacks receive:

  • 1B Tyler Locklear
  • RHP Juan Burgos
  • RHP Hunter Cranton

Eugenio Suárez contract

Eugenio Suárez is making $15 million in 2025 and will be a free agent after the season.

This story was updated to include new information.

This post appeared first on USA TODAY

  • Former NBA player Gilbert Arenas and five others were indicted on federal charges for operating an illegal gambling business.
  • The operation allegedly involved high-stakes poker games at an Encino mansion owned by Arenas.
  • Arenas faces up to five years in prison for each count if convicted.

Former NBA player Gilbert Arenas and five other people, including ‘a suspected high-level member of an Israeli transnational organized crime group,’ were arrested Wednesday, July 30 on a federal indictment alleging they operated an illegal gambling business in Encino, California, according the U.S. Department of Justice’s Attorney’s Office, Central District of California.

Arenas, 43, is charged with one count of conspiracy to operate an illegal gambling business, one count of operating an illegal gambling business and one count of making false statements to federal investigators.

Also charged with one count of conspiracy to operate an illegal gambling business and one count of operating an illegal gambling business:

  • Yevgeni Gershman, 49, a suspected organized crime figure from Israel
  • Evgenni Tourevski, 48
  • Allan Austria, 52
  • Yarin Cohen, 27
  • Ievgen Krachun, 43

According to the indictment that was unsealed Wednesday, July 30, Arenas and the other defendants ‘operated an illegal gambling business. Arenas rented out an Encino mansion he owned for the purpose of hosting high-stakes illegal poker games. At Arenas’ direction, Arthur Kats, 51, of West Hollywood, staged the mansion to host the games, found co-conspirators to host the games, and collected rent from the co-conspirators on Arenas’ behalf.

‘Gershman, Tourevski, Austria, and Cohen managed illegal ‘Pot Limit Omaha’ poker games, among other illegal games, at the Encino mansion, collected a ‘rake’ – a fee the house charged from each pot either as a percentage or a fixed amount per hand – and invited players to compete.

‘Gershman hired young women who, in exchange for tips, served drinks, provided massages, and offered companionship to the poker players. The women were charged a ‘tax’ – a percentage of their earnings from working the games. Chefs, valets, and armed security guards also were hired to staff these illegal poker games.’

Gershman and Valentina Cojocari, 35, are also charged with three additional counts: conspiracy to commit marriage fraud; marriage fraud; and making a false statement on an immigration document.

If convicted, the defendants face a statutory maximum sentence of five years in federal prison for each count.

Arenas spent 11 seasons in the NBA, including seven-plus seasons with the Washington Wizards. He was a three-time All-Star and three-time All-NBA selection. In the 2009-10 season, it was discovered Arenas had brought guns into the Wizards locker room and had an alteracation with then-teammate Javaris Crittenton involing firearms in the locker room. The NBA suspended both players indefinitely, and Arenas ended up serving a 50-game suspension.

This post appeared first on USA TODAY

PHOENIX — The Seattle Mariners, who made the painful mistake of trading third baseman Eugenio Suarez two years ago to the Arizona Diamondbacks only to watch him become one of the game’s premier power hitters, swallowed their pride Wednesday night and traded for him back.

Suarez, who has 36 homers and 87 RBIs, becomes the first player in baseball history to hit at least 35 homers before he was traded in-season.

“Super excited, it’s a great move,’’ Mariners MVP candidate Cal Raleigh told reporters after their game Wednesday night. “He’s pretty much everything you look for in a teammate. He’s supportive. Super nice. Keeps it light in the room. Always positive. And you add on to that, he’s a great player.

“We saw that when he was here the first time, and we were obviously all sad that he left, but we’re happy that he’s coming back …. Very, very excited for it. Obviously, we know how great a guy he is, how great he’s playing this year. Great, great add.”

It was the second deal the Mariners and Diamondbacks made in a week with the D-backs also trading first baseman Josh Naylor to Seattle for two pitching prospects. Now, they sent his corner infield teammate to provide the Mariners much-needed power to reach the postseason for only the second time since 2001 after near-misses the last two years.

The Mariners, fortunate that the market for Suarez never materialized the way the Diamondbacks envisioned, were able to pull off the deal without touching any of their prized prospects. The cost was first baseman Tyler Locklear, their ninth-best prospect, who leads all Triple-A hitters with 16 homers and 56 RBIs since June 1; and minor-league pitchers Hunter Cranton and Juan Burgos, their 16th- and 17th-ranked prospects, respectively.

Just like that, they now have a team built to win their first World Series championship in franchise history.

The Mariners (57-52) are five games behind the Houston Astros in the AL West, and are tied with the Texas Rangers for the third and final wild-card berth. Yet, with their star-studded rotation of Logan Gilbert, Bryan Woo, George Kirby, Luis Castillo and Bryce Miller, they can scare the living daylights out of any team in the postseason.

And now, they finally have the power they have long coveted, with Suarez hitting 53 home runs over the past year, trailing only Shohei Ohtani (60 homers) and Aaron Judge (58). Raleigh (41 homers) and Suarez (36) make the Mariners the second team in MLB history to enter August with at least two players having at least 35 homers, joining the 1961 Yankees who had Roger Maris (40) and Mickey Mantle (39).

The Mariners now have one of the deepest and most-talented lineups in the American League, rectifying the blunder they made two years ago when they traded Suarez.

The Mariners thought his career was in a steep decline after the 2023 season, which saw him hit .232 with 22 homers, 96 RBIs and a league-leading 214 strikeouts. The Mariners sent him to Arizona, receiving only minor-league reliever Carlos Vargas and backup catcher Seby Zavala, while saving about $11 million in salary.

It looked like a shrewd move when Suarez was struggling so badly — hitting just .193 — that the Diamondbacks considered designating him for assignment in late June 2024. He instead caught fire, hitting .307 with 20 homers and a .942 OPS in the second half, and never cooled off.

Now, all the Mariners need is for Suarez to stay hot for three more months, their starting pitching to stay healthy, maybe grab one more late-inning reliever by Thursday’s trade deadline, and take the franchise on a magical ride to its first World Series.

It has been a long time coming, but now the Mariners have the lineup, the pitching, and the burning desire to pull it off.

They’ve saved prized prospects long enough.

Now, it’s time for a parade.

Follow Nightengale on X: @BNightengale

This post appeared first on USA TODAY

The on-air relationship between ESPN and Shannon Sharpe appears to be over less than two weeks after the Pro Football Hall of Fame tight end and media commentator settled a $50 million lawsuit related to sexual assault and battery accusations by an ex-girlfriend.

The network has decided to cut ties with Sharpe, according to a report from The Athletic on Wednesday, July 30. Sharpe last appeared on ESPN in April, stepping away after the lawsuit was initially filed. But he publicly denied the allegations, calling it a ‘shakedown,’ and maintained his relationship with the accuser was ‘100% consensual.’

Sharpe said at the time he planned to return to ESPN’s airwaves when NFL training camps began ahead of the 2025 season.

The settlement in Sharpe’s case came to light on July 18 when Tony Buzbee, the attorney for the woman identified as ‘Jane Doe’ in the court filing, announced the sides had reached a resolution and the lawsuit would be dismissed. No details of the agreement were released.

The woman accused Sharpe of sexually assaulting her twice, in October 2024 and January 2025, after previously engaging in the intentional infliction of emotional distress. She said Sharpe became violent over the course of their relationship and recorded their sexual encounters without her consent. Sharpe never faced criminal charges in the matter.

‘On April 20, 2025, The Buzbee Law Firm filed a complaint in Nevada making several allegations against Shannon Sharpe on behalf of our client,’ Buzbee said in a statement on X. ‘Both sides acknowledge a long-term consensual and tumultuous relationship. After protracted and respectful negotiations, I’m pleased to announce that we have reached a mutually agreed upon resolution. All matters have now been addressed satisfactorily, and the matter is closed. The lawsuit will thus be dismissed with prejudice.’

Sharpe, 57, initially joined ESPN’s ‘First Take’ in 2023 for twice-weekly appearances alongside Stephen A. Smith after a long run debating Skip Bayless on FS1’s ‘Undisputed.’ He retired from the NFL in May 2004 after a 14-year career in which he won three Super Bowls and became the first tight end with more than 10,000 career receiving yards.

Sharpe also appears on the podcasts “Club Shay Shay” and “Nightcap” with former wide receiver Chad Ochocinco. They are produced and distributed by The Volume, a sports media company founded by FS1 star Colin Cowherd.

This post appeared first on USA TODAY

The canned cocktail maker High Noon is warning customers that some of its vodka seltzers were accidentally labeled as Celsius energy drinks.

In a recall notice posted to the Food and Drug Administration’s website, High Noon said an unspecified number of its Beach Variety packs contain cans are filled with High Noon vodka seltzer alcohol but have been mislabeled as Celsius Astro Vibe energy drink, Sparkling Blue Razz Edition, with a silver top.

Celsius Astro Vibe Energy Drink, Sparkling Blue Razz Edition.Celsius

The products were shipped to retailers in Florida, New York, Ohio, South Carolina, Virginia and Wisconsin from July 21 to July 23.

The recall was initiated after High Noon discovered that a shared packaging supplier mistakenly shipped empty Celsius cans to High Noon, it said.

No illnesses have been reported to date.

This post appeared first on NBC NEWS

President Donald Trump on Wednesday signed an executive order ending the de minimis trade loophole for low-value packages shipped from all countries.

The order, which takes effect Aug. 29, will subject any shipments of imported goods into the U.S. worth $800 or less to duties, the White House said.

Any goods shipped through the international postal network will be subject to tariff rates based on the value of the package and its country of origin.

The move comes after Trump in May shuttered the de minimis loophole for goods from China and Hong Kong. A federal trade court on Monday declined to block Trump’s de minimis ban, even after an auto parts retailer argued the action was unlawful and threatened its business.

Use of the de minimis provision has exploded in recent years as online shopping has become more prevalent. Ultra-cheap online retailers such as Temu and Shein have used the loophole to ship packages to American shoppers directly from China duty-free.

Shares of PDD Holdings, the parent company of Temu, dipped lower following the announcement.

The Trump administration has sought to close the loophole, calling it a “big scam” that hurts U.S. businesses. Officials have said de minimis facilitates shipments of fentanyl and other illicit substances, saying the packages are less likely to be inspected by customs agents.

The volume of de minimis shipments has skyrocketed to 309 million units so far this fiscal year, up from 115 million for all of last year, the White House said.

This post appeared first on NBC NEWS

As the global push toward electrification accelerates, lithium remains a critical piece of the energy transition.

Continued oversupply remained a persistent headwind for lithium prices through the first half of 2025. Demand for the battery metal jumped 29 percent year-over-year in 2024, fueled by surging electric vehicle sales and rising power needs from sectors like data centers and heavy industry.

Fastmarket’s analysts expect lithium demand to grow 12 percent annually through 2030, supported by structural trends such as renewable energy integration and battery energy storage.

However, a rapid increase in global supply — particularly from China, Australia and South America — has driven prices to multi-year lows, raising concerns about project economics and the sustainability of new production.

Against this backdrop, Canadian lithium stocks are gaining attention as investors look for companies positioned to benefit from long-term demand growth while navigating short-term price pressure.

1. NOA Lithium Brines (TSXV:NOAL)

Year-to-date gain: 58.82 percent
Market cap: C$488.32 million
Share price: C$0.30

NOA is a lithium exploration and development company with three projects in Argentina’s Lithium Triangle region. The company’s flagship Rio Grande project and prospective Arizaro and Salinas Grandes land packages total more than 140,000 hectares.

As NOA works to advance its flagship asset, the company brought on Hatch in April to lead the preliminary economic assessment (PEA).

The PEA will evaluate the project’s economic and development potential with a target production of 20,000 metric tons of lithium carbonate equivalent (LCE) annually, with a scalable plant design that could double capacity to 40,000 metric tons per year.

NOA has also been working to secure a water source in the arid region through a drilling program targeting fresh water. In late June, the company discovered a fresh water source at the project, located near high-grade lithium zones in the project’s northeast area. According to the company, the location means the water source could support future production facilities or evaporation ponds.

The well, drilled to 190 meters in the northern part of the property, is being tested and developed.

Shares of NOA reached a year-to-date high C$0.425 on July 17, 2025.

2. Wealth Minerals (TSXV:WML)

Year-to-date gain: 40 percent
Market cap: C$23.93 million
Share price: C$0.07

Wealth Minerals is focused on the acquisition and development of lithium projects in Chile, including the Yapuckuta project in Chile’s Salar de Atacama, as well as the Kuska Salar and Pabellón projects near the Salar de Ollagüe.

Wealth Minerals’ shares spiked to a year-to-date high of C$0.095 on February 9, 2025, following the company’s acquisition of the Pabellón project.

According to Wealth, Pabellón has been shortlisted by Chile’s Ministry of Mining as a potential site for a Special Lithium Operation Contract based on its geological and environmental suitability. Located in Northern Chile near the Bolivia border, the project spans 7,600 hectares across 26 exploration licenses about 70 kilometers south of the Salar de Ollagüe.

In May, Wealth formed a joint venture with the Quechua Indigenous Community of Ollagüe to advance the Kuska project. The new entity, Kuska Minerals SpA, is 95 percent owned by Wealth and 5 percent by the community, which also holds anti-dilution rights and a seat on the five-member board.

3. Avalon Advanced Materials (TSX:AVL)

Year-to-date gain: 37.5 percent
Market cap: C$38.26 million
Share price: C$0.055

Avalon Advanced Materials is a Canadian mineral development company focusing on integrating the Ontario lithium supply chain. Avalon is developing the Separation Rapids and Snowbank lithium projects near Kenora, Ontario, and the Lilypad lithium-cesium project near Fort Hope, Ontario.

Separation Rapids and Lilypad are part of a 40/60 joint venture between Avalon and SCR Sibelco, with Sibelco serving as the operator.

Avalon started the year with a revised mineral resource estimate for the Separation Rapids project, which boosted resources in the measured and indicated category by 28 percent.

Company shares rose to C$0.07, a year-to-date high, on July 15, the day after Avalon released its results for its fiscal quarter ended May 31.

A week later, Avalon announced an additional C$1.3 million in funding through its C$15 million convertible security agreement with Lind Global Fund II. The drawdown, expected to close within two weeks, will support project development and general corporate needs, according to the company.

4. Frontier Lithium (TSXV:FL)

Year-to-date gain: 20 percent
Market cap: C$125.41 million
Share price: C$0.54

Pre-production mining company Frontier Lithium aims to be a strategic and integrated supplier of premium spodumene concentrates as well as battery-grade lithium salts in North America.

The company’s flagship PAK lithium project, which is a joint venture with Mitsubishi (TSE:8058), holds the “largest land position and resource” in a premium lithium mineral district located in the Great Lakes region of Ontario, Canada. Frontier also owns the Spark deposit, located northwest of the PAK project.

Shares of Frontier Lithium reached a year-to-date high of C$0.79 on March 4. The stock uptick coincided with a government release reporting the federal and provincial governments supported the company’s plans to build a critical minerals refinery in Northern Ontario.

Once complete, the proposed lithium conversion facility will process lithium from the PAK mine project into approximately 20,000 metric tons of lithium salts per year.

In late May, Frontier released a definitive feasibility study for the mine and mill segment of its PAK project. The study outlines a 31 year mine life with average production of 200,000 metric tons of spodumene concentrate. As for the economics, it projects net revenue of C$11 billion, an after-tax NPV of C$932 million and a 17.9 percent internal rate of return.

5. Century Lithium (TSXV:LCE)

Year-to-date gain: 17.31 percent
Market cap: C$51.58 million
Share price: C$0.30

US-focused Century Lithium is currently advancing its Angel Island lithium project in Esmeralda County, Nevada. The company is also engaged in the pilot testing phase at its on-site lithium extraction facility, which will process material from the lithium-bearing claystone deposit.

On May 6, Century Lithium announced the successful completion of testwork on the direct lithium extraction (DLE) process at its demonstration plant.

The results exceeded expectations, showing 91.6 percent lithium recovery and an eluate grade of 575 milligrams per liter (mg/L) from a 328 mg/L lithium concentrate feed. The company says these improvements could significantly reduce capital and operating costs at its Angel Island project.

Shares of Century Lithium registered a year-to-date high of C$0.49 on May 19.

Recently, the company participated in First Phosphate’s (CSE:PHOS,OTCQB:FRSPF) successful production of commercial-grade lithium iron phosphate (LFP) 18650 battery cells.

As noted in the press release, the cells were made using North America-sourced materials, including lithium carbonate from Century’s Angel Island project in Nevada that was processed at its demonstration plant alongside high-purity phosphoric acid and iron from First Phosphate’s Bégin-Lamarche project in Québec, Canada.

Securities Disclosure: I, Georgia Williams, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

“Whatever is out of favor and hated at the moment, that’s probably what you need to buy,” he said. “Buy it when it’s boring and no one cares, then you get to ride the wave up.”

Barton also broke down his current portfolio, which holds a 30 percent weighting in precious metals—particularly gold—citing concerns over currency policies and the long-term upside for gold and silver.

Watch the interview above for more from Barton on the similarities between poker and resource investing.

Securities Disclosure: I, Georgia Williams, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

From established players to up-and-coming firms, Canada’s pharmaceutical company landscape is diverse and dynamic.

Canadian drug companies are working to discover and develop major innovations amidst an increasingly competitive global landscape. Rising technologies such as artificial intelligence are playing a role in the landscape as well.

Read on to learn about what’s been driving the share prices of the best-performing Canadian pharma stocks.

1. Cipher Pharmaceuticals (TSX:CPH,OTC:CPHRF)

Year-over-year gain: 48.2 percent
Market cap: C$330.79 million
Share price: C$12.33

Cipher Pharmaceuticals is a specialty pharma company with a diverse portfolio of treatments, including a range of dermatology and acute hospital care products. The company has out-licensed some of its offerings as well. Cipher began trading on the OTCQX Best Market under the symbol CPHRF in early 2024.

In addition to its current portfolio, Cipher has acquired Canadian rights to CF-101, a dermatology treatment for moderate to severe plaque psoriasis is currently expected to undergo Phase III clinical trials. The company is also conducting proof-of-concept studies on DTR-001, a topical treatment for removing tattoos.

In 2024, Cipher announced it had signed a definitive asset purchase agreement with ParaPRO for its US-based Natroba operations and global product rights, and the news caused Cipher’s share price to spike significantly.

During its Q1 results reporting in May 2025, the company announced a US$15 million debt repayment.

2. HLS Therapeutics (TSX:HLS)

Year-over-year gain: 42.03 percent
Market cap: C$154.95 million
Share price: C$4.90

HLS Therapeutics focuses on drugs for cardiovascular and central nervous system problems, often through partnerships. The company specializes in acquiring and commercializing pharmaceuticals that address unmet needs. Key commercial products include Vascepa, Clozaril for treatment-resistant schizophrenia and cholesterol-lowering therapies NEXLETOL and NEXLIZET.

Additionally, the company generates revenue from a diversified portfolio of royalty interests on various products marketed by third parties.

3. Medexus Pharmaceuticals (TSX:MDP,OTC:MEDXF)

Year-over-year gain: 23.25 percent
Market cap: C$92.9 million
Share price: C$2.81

Medexus Pharmaceuticals specializes in bringing drugs to treat rare diseases to North America. The company manages the entire process through its fully integrated operations, from acquiring and developing drugs to marketing and selling them. Some of its key products include treatments for hemophilia B and rheumatoid arthritis, as well as a line of drugs for autoimmune diseases like lupus and allergy treatments.

In November 2024, Medexus Pharmaceuticals announced it had successfully negotiated with the pan-Canadian Pharmaceutical Alliance to make treosulfan, which Medexus commercialized in Canada under the name Trecondyv, available to publicly funded drug programs and patients. Trecondyv is indicated as part of conditioning treatment prior to bone marrow transplants in patients with certain types of blood cancers.

In addition to Canada, Medexus has the exclusive commercialization rights to treosulfan in the US, where it received approval from the US Food and Drug Administration (FDA) in January 2025.

4. Satellos Bioscience (TSXV:MSCL,OTC:MSCLF)

Year-over-year gain: 18 percent
Market cap: C$102.26 million
Share price: C$0.59

Satellos Bioscience is a Canadian pharmaceutical company expanding treatment options for muscle disorders. The company has focused specifically on Duchenne muscular dystrophy, developing therapies to regenerate and repair muscle tissue by targeting the specific biological pathways involved. Its lead candidate SAT-3247 targets a protein called AAK1, which regulates the activity of stem cells that activate and differentiate new muscle fibers.

The company began enrolment for a multiple-ascending-dose arm of the Phase 1 study for SAT-3247 last November after no drug-related adverse events were reported in the single-ascending-dose group.

In May of this year, Satellos announced results from its Phase 1b trial, reporting SAT-3247 has shown positive safety and pharmacokinetic data and encouraging early functional results, clearing the path for a planned Phase 2 trial.

5. NurExone Biologic (TSXV:NRX,OTC:NRXBF)

Year-over-year gain: 1.41 percent
Market cap: C$44.18 million
Share price: C$0.72

NurExone Biologic is the biopharmaceutical company behind ExoTherapy, a drug delivery platform that uses exosomes, which are nano-sized extracellular vesicles, to create treatments for central nervous system disorders, spinal cord injuries and traumatic brain injuries. It is a less invasive alternative to cell transplantation, which requires surgery and carries the risk of rejection.

NurExone’s first nano-drug, ExoPTEN, uses a proprietary sIRNA sequence delivered with the ExoTherapy platform to treat spinal cord injuries. ExoPTEN received orphan drug designation from the US Food and Drug Administration (FDA) in October 2023, meaning it has been recognized as a potential treatment for rare medical conditions. The designation makes it eligible for incentives such as market exclusivity and regulatory assistance aimed at accelerating its development and approval.

The company released preclinical results from animal testing evaluating the efficacy of its nano-drug ExoPTEN in restoring lost vision at the end of 2024. In July 2025, preclinical studies indicated that ExoPTEN could improve walking quality in patients with spinal cord injuries.

Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Investor Insight

With high-quality, drill-ready assets with world-class discovery potential, Piche Resources is a compelling business case for investors looking to leverage a bull market for uranium and gold.

Overview

Piche Resources (ASX:PR2) is an ASX-listed mineral exploration company focused on uranium and gold exploration in Tier-1 jurisdictions: Western Australia and Argentina. The company holds 100 percent ownership of all of its projects and is supported by a highly experienced board and technical team.

Targeting globally significant discoveries in Tier-1 mineral provinces

Piche’s portfolio includes the advanced-stage Ashburton uranium project in Western Australia and two large-scale exploration projects in Argentina: the Cerro Chacon gold-silver project and the Sierra Cuadrada uranium project. These projects have delivered high-grade exploration results and are drill-ready, positioning the company to unlock significant shareholder value through systematic exploration programmes.

Piche has an internationally recognized board focused on creating long-term shareholder value, and an in-country technical team in Argentina with a proven track record of taking projects from discovery through to development.

Company Highlights

  • Flagship Ashburton uranium project in Western Australia with recent high-grade drilling results over wide intercepts.
  • Sierra Cuadrada uranium project in Argentina showing extensive near-surface mineralisation with assays up to 2.86 percent U₃O₈.
  • Cerro Chacon gold-silver project with high-grade surface results (up to 11.65 g/t gold and 333.7 g/t silver) across a 14 km mineralised corridor.
  • Fully permitted and EIA-approved for drilling at Cerro Chacon (Chacon South and Middle).
  • Large, 100-percent-owned tenement package across all projects (Ashburton: 335 sq km; Cerro Chacon: 414 sq km; Sierra Cuadrada: 1,310 km²).
  • Board of directors includes former leaders of Peninsula Energy, Orano, Rio Tinto Uranium and Barrick Gold.
  • Upcoming drill campaigns planned at Cerro Chacon and Ashburton to test multiple high-priority targets.

Key Projects

Gold: Cerro Chacon, Argentina

Cerro Chacon interpreted geology and tenement holding

Cerro Chacon is a large-scale, early-stage gold-silver exploration project located in the Chubut Province of Argentina. The project is situated within a region known for hosting world-class low-sulphidation epithermal systems, including Cerro Negro and Cerro Vanguardia. With multiple gold-bearing structures confirmed over a 14 km corridor, Cerro Chacon is emerging as a highly promising and underexplored precious metals system with substantial scale and grade potential.

Project Highlights

Location: ~40 km southwest of Paso de Indios, Chubut Province

Tenure: 414 sq km across multiple tenements

Highlights:

  • A 14 km-long mineralised corridor has been delineated across Chacon Grid, La Javiela and Toro Hosco prospects.
  • High-grade geochemical results include:
    • 11.65 g/t gold and 120.3 g/t silver at Toro Hosco
    • 333.7 g/t silver, 9.48 percent lead, and 8.57 percent zinc at La Javiela South
  • Maiden RC drilling programme of 57 holes (7,905 m) scheduled across three main targets:
    • Chacon Grid: 45 holes (5,590 m)
    • La Javiela: 8 holes (1,740 m)
    • Toro Hosco: 4 holes (575 m)
  • EIA approvals for Chacon South and Chacon Middle were received in May 2025, enabling drilling to proceed.
  • Vein systems range from 2 to 6 km in strike length and up to 50 m in width; hosted within structurally controlled low-sulphidation epithermal veins (LSEV).

Uranium: Ashburton Project, Australia

The Ashburton project is Piche’s flagship uranium exploration asset in Australia, situated in the Pilbara region of Western Australia. Located within a historically underexplored but highly prospective unconformity-related uranium district, the project provides the company with strong leverage to the growing global demand for uranium. The project is geologically analogous to world-class Proterozoic uranium systems, with multiple confirmed mineralised zones and a regional corridor of 60 km.

Project Highlights

  • Location: Pilbara region, ~1,150 km north of Perth
  • Tenure: 335 sq km following the recent application for tenement E52/4461 (214 sq km), adding to the existing 122 sq km holdings.
  • Highlights:
    • 2024 RC and diamond drilling confirmed high-grade uranium mineralisation at multiple stratigraphic levels.
    • Best intercepts include:
      • 3.45 m @ 5,129 ppm eU₃O₈ from 137.62 m (ARC006)
      • 10.48 m @ 1,412 ppm eU₃O₈ from 114.30 m (ADD005)
      • 2.42 m @ 2,681 ppm eU₃O₈ from 155.10 m (ADD003).
      • 7.86 m @ 2,266 ppm eU₃O₈ from 105.42 m (ADD006)
    • The company has outlined a 60 km structural corridor hosting multiple uranium occurrences including Angelo A & B, Canyon Creek, Ristretto and Atlantis.
    • Atlantis prospect: historical drilling returned up to 7,400 ppm U₃O₈ over 2.2 m; rock chip samples have returned up to 37 percent U₃O₈.

Uranium: Sierra Cuadrada, Argentina

Sierra Cuadrada is Piche’s primary uranium asset in Argentina, covering a vast area within the San Jorge Basin. This large-scale project has demonstrated strong surface uranium mineralisation with multiple drill-ready prospects. With mineralisation confirmed across extensive zones and supported by historical radiometric and geochemical data, Sierra Cuadrada has the potential to host multiple Tier-1 uranium deposits in a cost-effective, near-surface setting.

Teo 5 and 6 prospect 2024 auger drill programme

Project Highlights:

Location: San Jorge Basin, ~200 km north of Comodoro Rivadavia

Tenure: 1,310 sq km across multiple licences

Highlights:

  • The project area contains broad, flat-lying mineralisation at multiple stratigraphic levels.
  • High-grade uranium assays include:
    • 28,650 ppm U₃O₈ (2.86 percent) from rock chip sampling at Teo 8
    • 24,017 ppm U₃O₈ from channel sampling
    • 2,772 ppm U₃O₈ over 0.5m from auger drill sample
  • Mineralised zones extend over a strike of 60 sq km, with confirmed targets on the majority of tenements.
  • 2024 auger drilling and sampling confirmed uranium continuity across a sandstone and conglomerate sedimentary package with 14 samples exceeding 200 ppm U₃O₈.
  • Rock chip sampling has returned 114 samples >200ppm U₃O₈
  • RC drilling is planned to follow up on anomalies identified in the auger and channel sampling programmes.

Management Team

John (Gus) Simpson – Executive Chairman

John Simpson has over 37 years of experience in mineral exploration, development and mining. Previously the executive chairman and founder of Peninsula Energy Limited (ASX:PEN), a USA uranium producer.

Stephen Mann – Managing Director

Stephen Mann is a geologist with over 40 years of experience in exploration, discovery and development of mining projects, including 20 years in the uranium sector. Formerly the Australian managing director of Orano, the world’s third-largest uranium producer.

Pablo Marcet –Executive Director

Pablo Marcet is a senior geoscientist with 38 years of experience in exploration, discovery and development of mineral deposits. Currently an independent director of lithium producer Arcadium Lithium (NYSE:ALTM) and previously a director of Barrick Gold (NYSE:GOLD) and U3O8 (TSX:UWE).

Clark Beyer – Non-executive Director

Clark Beyer is an internationally recognized nuclear industry executive with over 35 years of experience. Formerly the managing director of Rio Tinto Uranium and currently principal of Global Fuel Solutions, providing strategic consulting to the international uranium and nuclear fuels market.

Stanley Macdonald – Non-executive Director

Stanley Macdonald is a nationally recognized mining entrepreneur, founding director and instrumental in the success of numerous ASX-listed companies, such as Giralia Resources, Northern Star and Redhill Iron. He is currently a director of Zenith Minerals.

This post appeared first on investingnews.com